- Home
- HLMN vs MYGN Comparison
HLMN vs MYGN Comparison
Compare HLMN & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLMN
- MYGN
- Stock Information
- Founded
- HLMN 1964
- MYGN 1991
- Country
- HLMN United States
- MYGN United States
- Employees
- HLMN N/A
- MYGN N/A
- Industry
- HLMN Industrial Machinery/Components
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HLMN Consumer Discretionary
- MYGN Health Care
- Exchange
- HLMN Nasdaq
- MYGN Nasdaq
- Market Cap
- HLMN 1.6B
- MYGN 744.7M
- IPO Year
- HLMN N/A
- MYGN 1995
- Fundamental
- Price
- HLMN $7.53
- MYGN $5.52
- Analyst Decision
- HLMN Buy
- MYGN Hold
- Analyst Count
- HLMN 5
- MYGN 15
- Target Price
- HLMN $11.25
- MYGN $15.14
- AVG Volume (30 Days)
- HLMN 1.3M
- MYGN 1.8M
- Earning Date
- HLMN 08-05-2025
- MYGN 08-05-2025
- Dividend Yield
- HLMN N/A
- MYGN N/A
- EPS Growth
- HLMN N/A
- MYGN N/A
- EPS
- HLMN 0.09
- MYGN N/A
- Revenue
- HLMN $1,481,633,000.00
- MYGN $831,300,000.00
- Revenue This Year
- HLMN $6.41
- MYGN N/A
- Revenue Next Year
- HLMN $6.57
- MYGN $6.68
- P/E Ratio
- HLMN $80.21
- MYGN N/A
- Revenue Growth
- HLMN 0.31
- MYGN 7.38
- 52 Week Low
- HLMN $6.55
- MYGN $3.81
- 52 Week High
- HLMN $12.08
- MYGN $29.30
- Technical
- Relative Strength Index (RSI)
- HLMN 49.52
- MYGN 55.99
- Support Level
- HLMN $6.75
- MYGN $4.90
- Resistance Level
- HLMN $7.31
- MYGN $5.50
- Average True Range (ATR)
- HLMN 0.22
- MYGN 0.25
- MACD
- HLMN 0.05
- MYGN 0.09
- Stochastic Oscillator
- HLMN 60.56
- MYGN 84.46
About HLMN Hillman Solutions Corp.
Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.